Your Basket 0


GenomeMe Labs Inc is a biotechnology company founded in 2015, based in Vancouver focusing on the development and manufacture of monoclonal IHC antibodies and qPCR based HPV kits for cervical cancer detection.

From antigen design to validation, GenomeMe has developed over 260+ immunohistochemistry (IHC) antibodies targeting critical markers you need to make your diagnosis with confidence. These have been tested in both normal and disease state and using knock out / knock in cell lines established in house.